The Middle East aesthetic injectable market size was estimated at USD 215.5 Million in 2025 and is projected to reach USD 434.1 million by 2033, growing at a CAGR of 9.1% from 2025 to 2033. This growth is fueled by the increasing awareness and acceptance of minimally invasive cosmetic procedures across the region, driven notably by social media influence and a widening patient demographic that now includes men and younger adults.
Rising disposable incomes and a flourishing medical tourism industry further expand the market, especially in key hubs like the UAE and Saudi Arabia. The rising number of geriatrics is becoming a key growth driver for the Middle East aesthetic injectables industry. According to the World Bank’s 2024 report, around 10% of the region’s population is now aged 65 and above, and this share is expected to keep growing in the coming years. As a result, demand is increasing for cosmetic solutions that address common age-related concerns such as wrinkles, skin laxity, and volume loss.
The growth of the Middle East aesthetic injectable market is fueled by technological progress, improved affordability, and easier access. Botox remains a preferred choice, but the addition of advanced non-invasive options like laser and radiofrequency treatments is giving people more ways to rejuvenate their skin and contour their bodies. At the same time, the rise of aesthetic clinics, medical spas, and loyalty programs is making these procedures more attainable for a wider audience. Botox and other injectables have become central to the region’s cosmetic medicine scene, attracting people across different age groups and reflecting evolving beauty standards, while continuing to drive strong market growth.
This product will be delivered within 2 business days.
Rising disposable incomes and a flourishing medical tourism industry further expand the market, especially in key hubs like the UAE and Saudi Arabia. The rising number of geriatrics is becoming a key growth driver for the Middle East aesthetic injectables industry. According to the World Bank’s 2024 report, around 10% of the region’s population is now aged 65 and above, and this share is expected to keep growing in the coming years. As a result, demand is increasing for cosmetic solutions that address common age-related concerns such as wrinkles, skin laxity, and volume loss.
The growth of the Middle East aesthetic injectable market is fueled by technological progress, improved affordability, and easier access. Botox remains a preferred choice, but the addition of advanced non-invasive options like laser and radiofrequency treatments is giving people more ways to rejuvenate their skin and contour their bodies. At the same time, the rise of aesthetic clinics, medical spas, and loyalty programs is making these procedures more attainable for a wider audience. Botox and other injectables have become central to the region’s cosmetic medicine scene, attracting people across different age groups and reflecting evolving beauty standards, while continuing to drive strong market growth.
Middle East Aesthetic Injectable Market Report Segmentation
This report forecasts revenue growth at the regional and country levels and provides an analysis of the latest industry trends in each of the sub-segments from 2021 to 2033. For this study, the analyst has segmented the Middle East aesthetic injectable market report based on product, end use, application, and country:Product Outlook (Revenue, USD Million, 2021-2033)
- Hyaluronic Acid (HA)
- Botulinum Toxin (Botox)
- Aquatic Light Injections
- Others
End Use Outlook (Revenue, USD Million, 2021-2033)
- Medical Spas
- Dermatology Clinics
- Hospitals
Application Outlook (Revenue, USD Million, 2021-2033)
- Facial Line Correction
- Lip Augmentation
- Face Lift
- Acne Scar Treatment
- Lipoatrophy Treatment
- Others
Country Outlook (Revenue, USD Million, 2021-2033)
- Middle East
Why should you buy this report?
- Comprehensive Market Analysis: Gain detailed insights into the market across major regions and segments.
- Competitive Landscape: Explore the market presence of key players.
- Future Trends: Discover the pivotal trends and drivers shaping the future of the market.
- Actionable Recommendations: Utilize insights to uncover new revenue streams and guide strategic business decisions.
This report addresses:
- Market intelligence to enable effective decision-making
- Market estimates and forecasts from 2018 to 2030
- Growth opportunities and trend analyses
- Segmental and regional revenue forecasts for market assessment
- Competition strategy and market share analysis
- Product innovation listings for you to stay ahead of the curve
This product will be delivered within 2 business days.
Table of Contents
Chapter 1. Methodology and Scope
Chapter 2. Executive Summary
Chapter 3. Middle East Aesthetic Injectable Market Variables, Trends & Scope
Chapter 4. Middle East Aesthetic Injectable Market: Product Estimates & Trend Analysis
Chapter 5. Middle East Aesthetic Injectable Market: End Use Estimates & Trend Analysis
Chapter 6. Middle East Aesthetic Injectable Market: Application Estimates & Trend Analysis
Chapter 7. Middle East Aesthetic Injectable Market: Country Estimates & Trend Analysis
Chapter 8. Competitive Landscape
List of Tables
List of Figures
Companies Mentioned
The leading players profiled in this Middle East Aesthetic Injectable market report include:- AbbVie Inc.
- GALDERMA
- Merz Pharma
- Daewoong Pharmaceutical Co., Ltd.
Table Information
| Report Attribute | Details |
|---|---|
| No. of Pages | 80 |
| Published | September 2025 |
| Forecast Period | 2025 - 2033 |
| Estimated Market Value ( USD | $ 215.5 Million |
| Forecasted Market Value ( USD | $ 434.1 Million |
| Compound Annual Growth Rate | 9.1% |
| Regions Covered | Middle East |
| No. of Companies Mentioned | 5 |
